Draft Guidance on Clinical Trials Recognises Needs of Non- Commercial Research
BMJ: British Medical Journal 2004 July 24; 329(7459): 191
Showing items related by title, author, creator and subject.
Guidance for Industry. Using a Centralized IRB Review Process in Multicenter Clinical Trials. Draft Guidance Unknown creator (United States. Food and Drug Administration [FDA]; Good Clinical Practice Program, Office of the Commissioner [OC]; Center for Drug Evaluation and Research [CDER]; Center for Biologics Evaluation and Research [CBER]; Office of Regulatory Affairs [ORA], 2005-03)